Skip to content
PICO Portalanswers from OpenAlex

MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program

PaperCitations, authors & open-access status

MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program is a paper indexed in PICO Portal from OpenAlex.

How many citations does MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program have?

PICO Portalcitation count

MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program has 233 citations in the OpenAlex counts PICO Portal stores.

When was MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program published?

PICO Portalyear

MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program has 2021 year in the PICO Portal index.

What is the open-access status of MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program?

PICO Portaloa status

MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program has gold oa status in the PICO Portal index.

What is the DOI of MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program?

PICO Portaldoi

The DOI for MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program is on the source record.

What is the PMID of MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program?

PICO Portalpmid

The PMID for MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program is on the source record.

What is the OpenAlex record for MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program?

PICO Portalopenalex

The OpenAlex for MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial